Discover
RAPT
RAPT Therapeutics Inc
58.02
2 x 41.75
2 x 74.24
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
58.01 -0.01 (0.02%)
| Ytd | 71.30% | |
| 1y | 547.54% |
57.98
day range
58.02
5.67
52 week range
58.02
| Open | 57.98 | Prev Close | 58.02 | Low | 57.98 | High | 58.02 | Mkt Cap | 1.68B |
| Vol | 10.85M | Avg Vol | 2.40M | EPS | -11.66 | P/E | N/A | Forward P/E | -21.38 |
| Beta | 0.44 | Short Ratio | 0.42 | Inst. Own | 110.57% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-05 | 50-d Avg | 49.94 | 200-d Avg | 27.42 | 1yr Est | 58.00 |
| Income Statement | |||
| Operating Expenses | 19.37M | ||
| Research and Development Expense | 12.03M | ||
| Selling, General and Administrative Expense | 7.34M | ||
| Operating Income | -19.37M | ||
| Net Income | -17.58M | ||
| Net Income Common Stock | -17.58M | ||
| Net Income Common Stock (USD) | -17.58M | ||
| Consolidated Income | -17.58M | ||
| Earnings per Basic Share | -0.65 | ||
| Earnings per Basic Share (USD) | -0.65 | ||
| Earnings per Diluted Share | -0.65 | ||
| Earning Before Interest & Taxes (EBIT) | -17.58M | ||
| Earning Before Interest & Taxes (USD) | -17.58M | ||
| Weighted Average Shares | 26.96M | ||
| Weighted Average Shares Diluted | 26.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 37.93M | ||
| Cash and Equivalents (USD) | 37.93M | ||
| Investments | 119.41M | ||
| Investments Current | 119.41M | ||
| Current Assets | 161.04M | ||
| Property, Plant & Equipment Net | 2.65M | ||
| Total Assets | 165.74M | ||
| Debt Current | 2.21M | ||
| Total Debt | 2.60M | ||
| Current Liabilities | 13.38M | ||
| Debt Non-Current | 387.00K | ||
| Total Liabilities | 13.76M | ||
| Accumulated Retained Earnings (Deficit) | -666.93M | ||
| Accumulated Other Comprehensive Income | 100.00K | ||
| Shareholders Equity | 151.98M | ||
| Shareholders Equity (USD) | 151.98M | ||
| Assets Non-Current | 4.69M | ||
| Total Debt (USD) | 2.60M | ||
| Liabilities Non-Current | 387.00K | ||
| Trade and Non-Trade Payables | 2.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 683.00K | ||
| Net Cash Flow from Financing | 36.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.96M | ||
| Issuance (Purchase) of Equity Shares | 36.00K | ||
| Net Cash Flow from Investing | 8.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.47M | ||
| Net Cash Flow from Operations | -12.46M | ||
| Share Based Compensation | 5.03M | ||